Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homologous toxins in other crotalid venoms refers to a group of structurally and functionally related proteins found in the venom of snakes within the Crotalinae subfamily, such as rattlesnakes, copperheads, and cottonmouths. These toxins primarily include phospholipase A2 (PLA2) enzymes, snake venom metalloproteinases (SVMPs), and serine proteases, which are responsible for the diverse clinical manifestations of snakebite envenomation (PMID: 30114438). They function by disrupting physiological processes, leading to symptoms such as systemic coagulopathy, local tissue necrosis, and neurotoxicity (PMID: 31603345). In the pharmaceutical industry, these toxins are the primary targets for polyvalent antivenoms, which utilize purified antibodies or antibody fragments to bind and neutralize the venom components (PMID: 22403236). The homology between these toxins across different species allows for the development of antivenoms with broad-spectrum efficacy against multiple snake types. Additionally, specific toxin families like PLA2 are being investigated as targets for small-molecule inhibitors like varespladib to provide rapid, field-deployable treatment options (PMID: 27383360). Understanding the molecular evolution and conservation of these toxins is essential for improving the potency and safety of modern snakebite therapeutics.
Antivenoms act by binding to the venom toxins, forming immune complexes that prevent the toxins from interacting with their biological targets and facilitating their clearance from the body (PMID: 22403236). Small molecule inhibitors like varespladib target the active site of phospholipase A2 enzymes to competitively inhibit their catalytic activity (PMID: 27383360).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Crotalid venom toxins.